Cel Sci CVM
NYSE CVM
$2.08 +0.02 (+0.73%)
As of: Oct 1, 2026 · 3:59 PM EDT

Cel Sci (CVM) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Cel Sci's Depreciation & Amortization (CF) was $946,370 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 1.3% from $959,009 a year earlier and down 1.0% from the prior quarter.

Analysis

Cel Sci (CVM) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cel Sci's Depreciation & Amortization (CF) was $3.83 million through Jun 30, 2026, down 2.2% year-over-year; for FY2025 (ended Sep 30, 2025), it was $3.89 million, down 2.1% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 12.5% (FY2020 to FY2025).
  • In earlier fiscal years, Depreciation & Amortization (CF) was $3.97 million in FY2024 (+0.3%), $3.96 million in FY2023 (+3.4%), $3.83 million in FY2022 (+71.6%) and $2.23 million in FY2021 (+3.3%).
  • The fiscal Q3 2026 figure marks the lowest quarterly Depreciation & Amortization (CF) since fiscal Q1 2022.
  • Compared with a year earlier, Depreciation & Amortization (CF) has declined for nine straight quarters, with an average decline of 1.9% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was fiscal Q3 2022 (growth of 78.5%); the worst was fiscal Q4 2025 (a decline of 3.1%).
  • Per Business Quant data, CVM's Depreciation & Amortization (CF) in the three fiscal quarters before Q3 2026 was $956,401 (Q2 2026), $964,422 (Q1 2026) and $960,850 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Cel Sci 3.69 Mn -21.96 Mn - 946,370.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 946,370.00
Mar 31, 2026 956,401.00
Dec 31, 2025 964,422.00
Sep 30, 2025 960,850.00
Jun 30, 2025 959,009.00
Mar 31, 2025 970,102.00
Dec 31, 2024 995,192.00
Sep 30, 2024 991,580.00
Jun 30, 2024 984,208.00
Mar 31, 2024 988,762.00
Dec 31, 2023 1.00 Mn
Sep 30, 2023 998,653.00
Jun 30, 2023 985,699.00
Mar 31, 2023 985,439.00
Dec 31, 2022 988,543.00
Sep 30, 2022 982,939.00
Jun 30, 2022 978,786.00
Mar 31, 2022 979,262.00
Dec 31, 2021 887,930.00
Sep 30, 2021 581,409.00
API Access

Cel Sci Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CVM&period=max&api_key=YOUR_API_KEY